4. Flaxseed oil (cold-pressed)
The ALA bomb — high plant omega-3, photosensitivity, and the critical secret of cold pressing.
Flaxseed oil in 1 minute
What does it provide? A high-ALA plant omega-3 source — with anti-inflammatory and lipid-profile-improving potential. Foundational element of vegetarian/vegan omega-3 strategy (a complement to or substitute for fish oil).
How much? 1–2 teaspoons (5–10 mL) per day — on salad, on cooked vegetables, in yogurt, in smoothies. Never for cooking.
When to avoid? Cold-pressed form is mandatory — never heat! Caution with anticoagulants (additive bleeding risk at high dose). After opening, store refrigerated and use within 4–6 weeks — oxidized oil is net harmful (lipid peroxides).
Flax (Linum usitatissimum) is one of humanity's earliest domesticated crops — 9,000-year-old finds from the Fertile Crescent, with double use: fiber from the stem (linen), oil from the seed. Ancient Egyptian mummies were wrapped in linen, and the seeds, beyond their food-psychological status, served as wound dressings and medicine. Hippocrates (5th century BCE) recommended them for inflammation and bowel complaints. In medieval Europe, Charlemagne's Capitulare de villis edict (around 800) made flax cultivation obligatory in imperial courts, partly for textile, partly as oil source.
The 19th-century industrial revolution celebrated linseed oil as a painter's material (its drying property is the medium of every oil painting!), with its food role pushed into the background. At the end of the 20th century, the "omega-3 revolution" (Dyerberg and Bang's Greenland Inuit research of the 1970s) put it back in the spotlight: flaxseed oil became the omega-3 symbol of the vegan/vegetarian movement. Since the 2000s, clinical research has been more nuanced: plant ALA bioactivity is real, but conversion to marine EPA/DHA is modest (per Plourde 2007, around 5–8% to EPA, 0–4% to DHA), so fish oil cannot be fully replaced. Modern flax-oil marketing often overplays the "miracle oil" message, while the true premium is fresh oil stored in dark glass, refrigerated, used within 4–6 weeks of opening — rancid flax oil is already net harmful to health.
Scientific Background
Flaxseed oil's roughly 50–58% ALA content is the highest among culinary oils — exceeding chia oil and perilla oil.[1908] ALA can be enzymatically converted in the body (delta-6 desaturase, delta-5 desaturase, elongases) to EPA and DHA. Conversion efficiency, however, is better in women (approx. 8–21% to EPA, Burdge 2002) and weak in men (≤ 8% to EPA, < 4% to DHA).[1901] So flaxseed oil cannot fully replace preformed EPA/DHA from algae/fish oil.[1902]
Clinical effects: meta-analyses (Khalesi 2015 on blood pressure[1903], Pan 2009 on lipid profile[1904]) show that 30 g/day of ground flaxseed or 2 tablespoons of flaxseed oil modestly lower systolic blood pressure (approx. 1.7 mmHg)[1907] and LDL cholesterol (approx. 6 mg/dL). The effect is consistent but modest.[1905] CVD-outcome RCTs (Alpha Omega Trial, 2010) showed no clear outcome benefit for ALA supplementation.[1906]
Oxidation is flaxseed oil's Achilles heel. Due to its high polyunsaturated fatty acid content, it is extremely sensitive to heat, light, and oxygen — open at room temperature it goes rancid within 1 week, refrigerated 4–6 weeks. The lipid peroxide content of rancid (oxidized) oil is a direct risk for cell-membrane damage — the "always healthy" attitude reverses here. Versions stabilized with tocopherol (vitamin E) or rosemary extract last longer; TBHQ stabilization is a sign of poor quality.
At the microbiome level, the oil itself carries no fiber — but whole flaxseed (in ground form) contains large amounts of insoluble fiber, mucilage, and lignans (secoisolariciresinol diglucoside, SDG), which in the colon are converted to enterolignans (enterodiol, enterolactone) — these are microbiome substrates and hormonally active. So anyone choosing flaxseed oil over whole flaxseed loses precisely the most important microbiome effect.
- + Cool foods (salad, yogurt, cottage cheese, smoothie, kefir): flaxseed oil cannot be cooked — always stir into cold food.
- + Freshly ground flaxseed, chia, walnut: "omega-3 stack" — different forms, synergistic effect.
- + Vitamin E sources (almond, hazelnut, sunflower seed): vitamin E is needed for oxidative protection of polyunsaturated fatty acids.
- + Antioxidant-rich matrix (berries, cocoa, leafy greens): against in vivo lipid peroxidation.
- + Fish (if not vegan): complementary omega-3 strategy — flax oil provides ALA, fish provides preformed EPA/DHA.
- + Rustic pattern: cracklings + red onion + cottage cheese → flaxseed oil drops + freshly ground flaxseed on top — modern adaptation, high omega-3 + B-vitamin + live cultures.
- + Breakfast oatmeal + flaxseed oil (cooled) + berries: fiber + omega-3 + polyphenol combination.
- HIGH HEAT! Never fry or cook with flaxseed oil. ❌ The high PUFA content drives rapid oxidation, polymerization, acrolein, and lipid peroxide formation above 60 °C. The "I'll warm it slightly" approach does NOT work.
- Anticoagulants (warfarin, DOACs, clopidogrel, aspirin) with high-dose flaxseed-oil supplement: ALA is a weak antiaggregant; additive bleeding risk at high doses. Dietary amounts (1–2 tsp/day) are generally safe.
- Rancid, oxidized flaxseed oil (yellow-brown color, sticky texture, paint smell): lipid peroxides have net harmful effects — cell-membrane damage, increased inflammation. Never use a "forgotten" bottle.
- Flaxseed oil stored in summer sun or a sunlit apartment: UV photo-oxidation starts within seconds. Dark glass and refrigerator are mandatory.
- Acute phase of hyperthyroidism: flaxseed (though not the oil) has goitrogenic-cyanogenic glycoside content — a theoretical issue, but practically absent in the oil.
- Active gastric ulcer, reflux flare: spoonful flaxseed-oil consumption on empty stomach should be avoided — emulsification issues.
- Active bleeding, recent surgery, anticoagulation in unstable range: high-dose flaxseed-oil supplementation should be avoided.
- 2 weeks before planned surgery: discontinue supplemental flax oil.
- Hormone-sensitive cancers (estrogen-receptor positive breast cancer) in active treatment: lignans have phytoestrogen activity — the oil contains small amounts, whole flax much more. Consult oncologist.
- First trimester of pregnancy: human data on supplemental doses are limited; dietary quantities are safe.
- Severe acute hepatitis, liver failure: fat digestion is impaired — all dietary fat should be restricted.
- Acute pancreatitis: fat restriction is mandatory.
- IgE-mediated flaxseed allergy: rare but exists (particularly in the Mediterranean) — strict avoidance.
- Acute diverticulitis flare: whole flaxseed's fiber content is irritating; the oil is acceptable.
Daily serving: 1–2 teaspoons (5–10 mL) — never with heat.
Preparation methods:
- Salad dressing: vinegar/lemon juice + flax oil + salt + pepper directly on salad (don't keep in mixture long; the citric acid stabilizes but not permanently).
- Drizzled onto yogurt/cottage cheese/kefir — rustic-modern pattern.
- Into smoothies, 1 tsp at the end of blending — not high-speed pulsed.
- On cooked-steamed vegetables when plating — never during cooking.
Classic patterns:
- "Lőrinc cottage cheese": low-fat cottage cheese + freshly ground flaxseed + flax oil + red onion + radish + freshly cracked pepper — rustic + modern omega-3 fusion
- Breakfast oatmeal: oats cooked, removed from heat + berries + 1 tsp flax oil + almond slivers
- Avocado bowl: roasted sweet potato + half avocado + raw leafy greens + flax oil + tahini
- Winter salad: sauerkraut + grated carrot + apple + flax oil + freshly ground flaxseed
Storage: in dark glass, in the cool zone of the refrigerator (NOT on the door), airtight, 4–6 weeks after opening. When buying: check the date. "Best before" max 6 months from pressing.
What not to do: Do NOT fry, do NOT heat, do NOT store in clear glass, do NOT leave on the shelf in summer. Discard rancid-paint-smelling oil immediately.
References
[1901] Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002;88(4):411–420. . 2002. Link
The extent to which women of reproductive age are able to convert the n-3 fatty acid alpha-linolenic acid (ALNA) to eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA) was investigated in vivo by measuring the concentrations of labelled fatty acids in plasma for 21 d following the ingestion of [U-13C]ALNA (700 mg). [13C]ALNA excursion was greatest in cholesteryl ester (CE) (224 (sem 70) micromol/l over 21 d) compared with triacylglycerol (9-fold), non-esterified fatty acids (37-fold) and phosphatidylcholine (PC, 7-fold). EPA excursion was similar in both PC (42 (sem 8) micromol/l) and CE (42 (sem 9) micromol/l) over 21 d. In contrast both [13C]DPA and [13C]DHA were detected predominately in PC (18 (sem 4) and 27 (sem 7) micromol/l over 21 d, respectively). Estimated net fractional ALNA inter-conversion was EPA 21 \%, DPA 6 \% and DHA 9 \%. Approximately 22 \% of administered [13C]ALNA was recovered as 13CO2 on breath over the first 24 h of the study. These results suggest differential partitioning of ALNA, EPA and DHA between plasma lipid classes, which may facilitate targeting of individual n-3 fatty acids to specific tissues.
[1902] Plourde M, Cunnane SC. Extremely limited synthesis of long chain polyunsaturates in adults: implications for their dietary essentiality and use as supplements. Appl Physiol Nutr Metab 2007;32(4):619–634. . 2007. Link
There is considerable interest in the potential impact of several polyunsaturated fatty acids (PUFAs) in mitigating the significant morbidity and mortality caused by degenerative diseases of the cardiovascular system and brain. Despite this interest, confusion surrounds the extent of conversion in humans of the parent PUFA, linoleic acid or alpha-linolenic acid (ALA), to their respective long-chain PUFA products. As a result, there is uncertainty about the potential benefits of ALA versus eicosapentaenoic acid (EPA) or docosahexaenoic acid (DHA). Some of the confusion arises because although mammals have the necessary enzymes to make the long-chain PUFA from the parent PUFA, in vivo studies in humans show that asymptotically equal to 5\% of ALA is converted to EPA and <0.5\% of ALA is converted to DHA. Because the capacity of this pathway is very low in healthy, nonvegetarian humans, even large amounts of dietary ALA have a negligible effect on plasma DHA, an effect paralleled in the omega6 PUFA by a negligible effect of dietary linoleic acid on plasma arachidonic acid. Despite this inefficient conversion, there are potential roles in human health for ALA and EPA that could be independent of their metabolism to DHA through the desaturation - chain elongation pathway.
[1903] Khalesi S et al. Flaxseed consumption may reduce blood pressure: a systematic review and meta-analysis of controlled trials. J Nutr 2015;145(4):758–765. . 2015. Link
A systematic review and meta-analysis of controlled trials examining the potential blood-pressure-lowering effect of flaxseed consumption.
[1904] Pan A et al. Meta-analysis of the effects of flaxseed interventions on blood lipids. Am J Clin Nutr 2009;90(2):288–297. . 2009. Link
BACKGROUND: Several clinical trials have investigated the effects of flaxseed and flaxseed-derived products (flaxseed oil or lignans) on blood lipids; however, the findings have been inconsistent. OBJECTIVE: We aimed to identify and quantify the effectiveness of flaxseed and its derivatives on blood lipid profiles. DESIGN: A comprehensive literature search was performed on the basis of English reports of randomized controlled trials of flaxseed or its derivatives on lipid profiles in adults, which were published from January 1990 to October 2008. Attempts also were made to access unpublished data. Study quality was assessed by using the Jadad score, and a meta-analysis was conducted. RESULTS: Twenty-eight studies were included.
[1905] Rodriguez-Leyva D et al. Potent antihypertensive action of dietary flaxseed in hypertensive patients. Hypertension 2013;62(6):1081–1089. . 2013. Link
Flaxseed contains ω-3 fatty acids, lignans, and fiber that together may provide benefits to patients with cardiovascular disease. Animal work identified that patients with peripheral artery disease may particularly benefit from dietary supplementation with flaxseed. Hypertension is commonly associated with peripheral artery disease. The purpose of the study was to examine the effects of daily ingestion of flaxseed on systolic (SBP) and diastolic blood pressure (DBP) in peripheral artery disease patients. In this prospective, double-blinded, placebo-controlled, randomized trial, patients (110 in total) ingested a variety of foods that contained 30 g of milled flaxseed or placebo each day over 6 months. Plasma levels of the ω-3 fatty acid α-linolenic acid and enterolignans increased 2- to 50-fold in the flaxseed-fed group but did not increase significantly in the placebo group.
[1906] Alpha Omega Trial Group. n-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010;363(21):2015–2026. . 2010. Link
BACKGROUND: Results from prospective cohort studies and randomized, controlled trials have provided evidence of a protective effect of n-3 fatty acids against cardiovascular diseases. We examined the effect of the marine n-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and of the plant-derived alpha-linolenic acid (ALA) on the rate of cardiovascular events among patients who have had a myocardial infarction. METHODS: In a multicenter, double-blind, placebo-controlled trial, we randomly assigned 4837 patients, 60 through 80 years of age (78\% men), who had had a myocardial infarction and were receiving state-of-the-art antihypertensive, antithrombotic, and lipid-modifying therapy to receive for 40 months one of four trial margarines: a margarine supplemented with a combination of EPA and DHA (with a targeted additional daily intake of 400 mg of EPA-DHA), a margarine supplemented with ALA (with a targeted additional daily intake of 2 g of ALA), a margarine supplemented with EPA-DHA and ALA, or a placebo margarine. The primary end point was the rate of major cardiovascular events, which comprised fatal and nonfatal cardiovascular events and cardiac interventions. Data were analyzed according to the intention-to-treat principle, with the use of Cox proportional-hazards models. RESULTS: The patients consumed, on average, 18.8 g of margarine per day, which resulted in additional intakes of 226 mg of EPA combined with 150 mg of DHA, 1.9 g of ALA, or both, in the active-treatment groups.
[1907] Caligiuri SP et al. Flaxseed for hypertension: implications for blood pressure regulation. Curr Hypertens Rep 2014;16(12):499. . 2014. Link
A review discussing flaxseed in hypertension and its implications for blood pressure regulation.
[1908] EFSA. Scientific Opinion on dietary reference values for fats, including omega-3 PUFAs. EFSA Journal 2010;8(3):1461. . 2010. Link
An EFSA scientific opinion on dietary reference values for fats, including omega-3 PUFAs.